• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COPD 更新:病理生理学和治疗方面有哪些新进展?

COPD updates: what's new in pathophysiology and management?

机构信息

Division of Pulmonary and Critical Care, Department of Internal Medicine, Tannourine Governmental Hospital, Batroun, Lebanon.

出版信息

Expert Rev Respir Med. 2013 Aug;7(4):429-37. doi: 10.1586/17476348.2013.814392.

DOI:10.1586/17476348.2013.814392
PMID:23964630
Abstract

The historic perspective that used to define chronic obstructive pulmonary disease has changed. As reviewed in this article, it is based on a better understanding of the underlying inflammatory airflow obstruction and a multidimensional classification, which mostly targets a subgroup called 'frequent exacerbators'. Clinical and radioimaging predictors are the stamina for an aggressive therapeutic approach. A simplified explanation of the updated Global Initiative for Obstructive Lung Disease guidelines will ease the burden of treatment selection.

摘要

慢性阻塞性肺疾病的历史定义已经发生了变化。本文综述了这一变化,其基础是对潜在炎症性气流阻塞和多维分类的更好理解,该分类主要针对所谓的“频繁加重者”亚组。临床和放射影像学预测指标是积极治疗方法的耐力。对更新后的全球阻塞性肺病倡议指南的简化解释将减轻治疗选择的负担。

相似文献

1
COPD updates: what's new in pathophysiology and management?COPD 更新:病理生理学和治疗方面有哪些新进展?
Expert Rev Respir Med. 2013 Aug;7(4):429-37. doi: 10.1586/17476348.2013.814392.
2
Issues in pulmonary function testing for the screening and diagnosis of chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病筛查和诊断的肺功能测试中的问题。
Curr Opin Pulm Med. 2012 Mar;18(2):104-11. doi: 10.1097/MCP.0b013e32834feae7.
3
How can we define well-controlled chronic obstructive pulmonary disease?我们如何定义控制良好的慢性阻塞性肺疾病?
Expert Rev Respir Med. 2013 Apr;7(2 Suppl):3-15. doi: 10.1586/ers.13.15.
4
Outcomes and markers in the assessment of chronic obstructive pulmonary disease.慢性阻塞性肺疾病评估中的结果与标志物
Eur Respir J. 2006 Apr;27(4):822-32. doi: 10.1183/09031936.06.00145104.
5
Updates in the management of stable chronic obstructive pulmonary disease.稳定期慢性阻塞性肺疾病管理的进展
Postgrad Med. 2015;127(7):758-70. doi: 10.1080/00325481.2015.1084212. Epub 2015 Sep 2.
6
A review of the GOLD guidelines for the diagnosis and treatment of patients with COPD.慢性阻塞性肺疾病患者诊断与治疗的全球慢性阻塞性肺疾病倡议(GOLD)指南综述。
Int J Clin Pract. 2008 Aug;62(8):1219-36. doi: 10.1111/j.1742-1241.2008.01807.x. Epub 2008 Jun 28.
7
The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)--why and what?慢性阻塞性肺疾病全球诊断、管理和预防策略(GOLD)2011年修订版——为何修订及修订内容?
Clin Respir J. 2012 Oct;6(4):208-14. doi: 10.1111/crj.12002.
8
Future perspectives in COPD.慢性阻塞性肺疾病的未来展望
Respir Med. 2005 Dec;99 Suppl B:S41-8. doi: 10.1016/j.rmed.2005.09.014. Epub 2005 Oct 26.
9
Chronic obstructive pulmonary disease outcome measurements: what's important? What's useful?慢性阻塞性肺疾病的结局测量:什么是重要的?什么是有用的?
Proc Am Thorac Soc. 2005;2(4):267-71; discussion 290-1. doi: 10.1513/pats.200504-036SR.
10
Which pulmonary function tests best differentiate between COPD phenotypes?哪些肺功能测试最能区分 COPD 表型?
Respir Care. 2012 Jan;57(1):50-57; discussion 58-60. doi: 10.4187/respcare.01585.

引用本文的文献

1
Association between the number and size of intrapulmonary lymph nodes and chronic obstructive pulmonary disease severity.肺内淋巴结数量和大小与慢性阻塞性肺疾病严重程度之间的关联。
PeerJ. 2020 Jul 3;8:e9166. doi: 10.7717/peerj.9166. eCollection 2020.
2
Impaired mRNA Expression of the Migration Related Chemokine Receptor CXCR4 in Mesenchymal Stem Cells of COPD Patients.慢性阻塞性肺疾病(COPD)患者间充质干细胞中迁移相关趋化因子受体CXCR4的mRNA表达受损
Int J Inflam. 2017;2017:6089425. doi: 10.1155/2017/6089425. Epub 2017 Jul 19.